Publications by authors named "Martha Kienzle"

Article Synopsis
  • The study focused on pediatric in-hospital CPR events, particularly those involving bradycardia with poor perfusion, to evaluate the effects of early epinephrine on survival outcomes in children.
  • Researchers analyzed data from the ICU-RESUS trial, which involved CPR events that lasted 2 minutes or longer, examining the timing of epinephrine administration and the development of pulselessness.
  • Findings indicated that early epinephrine did not significantly improve the chances of survival or favorable neurological outcomes, while a high percentage of patients experienced pulselessness within the first few minutes of CPR.
View Article and Find Full Text PDF

Objectives: Data to support epinephrine dosing intervals during cardiopulmonary resuscitation (CPR) are conflicting. The objective of this study was to evaluate the association between epinephrine dosing intervals and outcomes. We hypothesized that dosing intervals less than 3 minutes would be associated with improved neurologic survival compared with greater than or equal to 3 minutes.

View Article and Find Full Text PDF
Article Synopsis
  • A study found a potential link between the use of noninvasive positive pressure ventilation (NIPPV) in children with bronchiolitis and the occurrence of in-hospital cardiac arrest (IHCA).
  • In a retrospective analysis of over 4,600 ICU admissions, only 1.2% experienced IHCA, with most cases involving invasive mechanical ventilation (IMV) rather than NIPPV.
  • The data suggested that NIPPV might actually lower the odds of IHCA compared to IMV, indicating it could be a safer option for managing respiratory support in these patients.
View Article and Find Full Text PDF

Background: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an inflammatory disorder of the CNS with a variety of clinical manifestations, including cerebral edema.

Case Summary: A 7-year-old boy presented with headaches, nausea, and somnolence. He was found to have cerebral edema that progressed to brainstem herniation.

View Article and Find Full Text PDF

Objectives: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an immune-mediated neuroinflammatory disorder leading to demyelination of the CNS. Interleukin (IL)-6 receptor blockade is under study in relapsing MOGAD as a preventative strategy, but little is known about the role of such treatment for acute MOGAD attacks.

Methods: We discuss the cases of a 7-year-old boy and a 15-year-old adolescent boy with severe acute CNS demyelination and malignant cerebral edema with early brain herniation associated with clearly positive serum titers of MOG-IgG, whose symptoms were incompletely responsive to standard acute therapies (high-dose steroids, IV immunoglobulins (IVIGs), and therapeutic plasma exchange).

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze respiratory failure characteristics in children before experiencing in-hospital cardiac arrest (IHCA) and how these factors relate to survival rates.
  • It involved reviewing data from a cohort of children under 18 who received CPR while on invasive mechanical ventilation in ICUs between January 2017 and June 2021, focusing on their respiratory conditions just before the arrest.
  • Findings indicated that many patients had severe respiratory issues leading up to the arrest, and those with higher oxygen needs and more significant oxygenation failure had poorer chances of survival.
View Article and Find Full Text PDF

Aims: The primary objective was to determine the association between clinician-reported use of end-tidal CO2 (ETCO2) or diastolic blood pressure (DBP) to monitor cardiopulmonary resuscitation (CPR) quality during pediatric in-hospital cardiac arrest (pIHCA) and survival outcomes.

Design: A retrospective cohort study was performed in two cohorts: (1) Patients with an invasive airway in place at the time of arrest to evaluate ETCO2 use, and (2) patients with an arterial line in place at the time of arrest to evaluate DBP use. The primary exposure was clinician-reported use of ETCO2 or DBP.

View Article and Find Full Text PDF

Objectives: Pediatric Advanced Life Support (PALS) guidelines include weight-based epinephrine dosing recommendations of 0.01 mg/kg with a maximum of 1 mg, which corresponds to a weight of 100 kg. Actual practice patterns are unknown.

View Article and Find Full Text PDF

Animal studies of cardiac arrest suggest that shorter epinephrine dosing intervals than currently recommended (every 3-5 min) may be beneficial in select circumstances. To evaluate the association between epinephrine dosing intervals and pediatric cardiac arrest outcomes. Single-center retrospective cohort study of children (<18 years of age) who received ⩾1 minute of cardiopulmonary resuscitation and ⩾2 doses of epinephrine for an index in-hospital cardiac arrest.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on pediatric resuscitation practices during the COVID-19 pandemic, highlighting safety risks for healthcare providers and quality of patient care.
  • A multi-institutional survey revealed that 60% of the 130 U.S. PICUs responded, with 62% having admitted COVID-19 patients and 33% activating resuscitation teams for them.
  • Major changes in response systems included limiting personnel in patient rooms (96%), restricting resident involvement (91%), and using enhanced protective equipment (73%), with many centers implementing new technology and modifying procedures for intubation during resuscitation.
View Article and Find Full Text PDF

Entry coreceptor use by HIV-1 plays a pivotal role in viral transmission, pathogenesis and disease progression. In many HIV-1 infected individuals, there is an expansion in coreceptor use from CCR5 to include CXCR4, which is associated with accelerated disease progression. While targeting HIV-1 envelope interactions with coreceptor during viral entry is an appealing approach to combat the virus, the methods of determining coreceptor use and the changes in coreceptor use that can occur during disease progression are important factors that may complicate the use of therapies targeting this stage of HIV-1 replication.

View Article and Find Full Text PDF

R5X4 HIV-1 has impaired utilization of CCR5 on primary CD4+ lymphocytes but the mechanisms responsible are not well defined. Using a panel of diverse R5X4 Envs we identified a spectrum of CCR5 use on CD4+ lymphocytes. Greater lymphocyte CCR5 use correlated with relative resistance to CCR5 mAbs and small molecule antagonists.

View Article and Find Full Text PDF

Infiltration of activated monocytes into the brain is a prerequisite for the development of various neurological disorders such as HIV-associated dementia, multiple sclerosis, and other inflammatory processes. In these pathologies, the chemokine SDF-1alpha (CXCL12) is over-expressed and might attract monocytes into the CNS. We demonstrate here that SDF-1alpha stimulates migration of monocytes through its receptor, CXCR4, and decreases monocyte adherence to surfaces coated with ICAM-1, a ligand for beta(2) integrins.

View Article and Find Full Text PDF
Article Synopsis
  • - Recently, a mouse model called BPH/5 was discovered that naturally develops preeclampsia symptoms, showing that problems in the placenta could lead to these maternal health issues.
  • - Increased levels of reactive oxygen species (ROS) were found in the placentas of BPH/5 mice early in pregnancy, linked to reduced antioxidant activity, indicating these factors might contribute to preeclampsia's development.
  • - Treatment with the antioxidant Tempol improved fetal health and reduced maternal symptoms like high blood pressure, suggesting that managing oxidative stress could be a promising approach for tackling preeclampsia.
View Article and Find Full Text PDF

Preeclampsia is a prevalent and potentially devastating disorder of pregnancy. Characterized by a sudden spike in blood pressure and urinary protein levels, it is associated with significant obstetric complications. BPH/5 is an inbred mouse model of preeclampsia with borderline hypertension before pregnancy.

View Article and Find Full Text PDF